Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Enveric Biosciences, Inc. (ENVB) had Weighted-Average Shares Outstanding (Diluted) of 2.16M for the most recently reported fiscal year, ending 2023-12-31.
Income Statement Financials | |
-- |
|
$-17.46M |
|
-- |
|
-- |
|
$16.45M |
|
$-16.45M |
|
$-0.81M |
|
$-17.26M |
|
$-17.26M |
|
$-17.29M |
|
$-17.29M |
|
$-17.29M |
|
$-17.29M |
|
$-16.45M |
|
$-16.04M |
|
2.16M |
|
Weighted-Average Shares Outstanding (Diluted) |
2.16M |
$-8.09 |
|
$-8.09 |
|
Balance Sheet Financials | |
$3.58M |
|
$0.51M |
|
$0.72M |
|
$4.30M |
|
$2.34M |
|
-- |
|
-- |
|
$2.34M |
|
$1.96M |
|
$1.75M |
|
$1.96M |
|
2.74M |
|
Cash Flow Statement Financials | |
$-14.09M |
|
$0.01M |
|
$-1.34M |
|
$17.72M |
|
$2.29M |
|
$-15.44M |
|
$2.15M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
1.53 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.08M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-883.89% |
|
-990.70% |
|
-402.15% |
|
-883.88% |
|
$0.71 |
|
$-6.52 |
|
$-6.53 |